Our results tend not to aid the cost-effectiveness of including cytisine to BS for people who smoke who will be recently diagnosed with pulmonary TB. In the absence of more practical using tobacco cessation assist, foreseeable future experiments should really examine the cost-performance of non-pharmacological cessation interventions in LMICs, pres